Infection control risks

Journal of Hospital Infection

Volumn 71, Issue 2, 2009, Pages 103-107

  Millar, M ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Infection; Risk compensation; Risks

Indexed keywords

METICILLIN;

CLINICAL PRACTICE; HEALTH BEHAVIOR; HEALTH PRACTITIONER; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL LITERATURE; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOMENCLATURE; PATIENT ATTITUDE; PATIENT CARE; PATIENT SAFETY; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TREATMENT PLANNING;

HUMANS; INFECTION CONTROL; RISK; RISK MANAGEMENT;

EID: 58249086351     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.10.010     Document Type: Review

References (21)

1. Anonymous. First report of harmonisation of risk assessment procedures-part 2 (2000), European Commission, Brussels
2. Anonymous. Healthcare risk assessment made easy (2007), National Patient Safety Agency, London
3. Anonymous. Best practice in managing risk (June 2007), Department of Health, London
4. Alberg C., Bingley W., Bowers L., et al. Learning materials on mental health: risk assessment (2006), University of Manchester Department of Health, Manchester
5. Edmond M, Lyckholm L, Diekema D. Ethical implications of active surveillance cultures and contact precautions for controlling multidrug resistant organisms in the hospital setting. Public Health Ethics. doi:10.1093/phe/phn014.
6. Kant I. The metaphysics of morals. Translated by Gregor MJ (1996), Cambridge University Press, Cambridge
7. Childress J.F., Faden R.R., Gaare R.D., et al. Public health ethics: mapping the terrain. J Law Med Ethics 30 (2002) 170-178
8. Mangan J. An historical analysis of the doctrine of double effect. Theol Stud 10 (1949) 41-61
9. Dancer S.J. Considering the introduction of universal MRSA screening. J Hosp Infect 69 (2008) 315-320
10. Millar M.R. Risk assessment in infection control: which risks?. Infect Control Hosp Epidemiol 29 (2008) 381-382
11. Schutz H., Wiedemann P.M., Hennings W., Mertens J., and Clauberg M. Comparative risk assessment (2006), Wiley-VCH, Weinheim
12. Fisman D.N., Mittleman M.A., Sorock G.S., and Harris A.D. Willingness to pay to avoid sharps-related injuries: a study in injured health care workers. Am J Infect Control 30 (2002) 283-287
13. Millar M.R., Coast J., and Ashcroft R. Are meticillin-resistant blood stream infection targets fair to those with other types of healthcare associated infection or cost-effective?. J Hosp Infect 69 (2008) 1-5
14. Daniels N. Accountability for reasonableness. Br Med J 321 (2000) 1300-1301
15. Peacock S., Ruta D., Milton C., Donaldson C., Bate A., and Murtagh M. Using economics to set pragmatic and ethical priorities. Br Med J 332 (2006) 482-485
16. Ham C. The future of the NHS. Br Med J 313 (1996) 1277-1278
17. Mental capacity act (2005) (2005), Stationery Office, London
18. Adams J. Risk (1995), University College London Press, London
19. Wilde G.J.S. Target risk 2 (2001), PDE Publications, Toronto
20. Cassell M.M., Halperin D.T., Shelton J.D., and Stanton D. Risk compensation: the Achilles' heel of innovations in HIV prevention. Br Med J 332 (2006) 605-607
21. Hedlund J. Risky business: safety regulations, risk compensation, and individual behaviour. Inj Prev 6 (2000) 82-89